JENNIFER DYER: Open Payments
NPI 1194246876 · MCMINNVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$580 in 36 payments from 9 companies in 2025. Trend: 2023 $574 · 2024 $505 · 2025 $580
Food & beverage: $580
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 17 | $199 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $88 |
| Novo Nordisk Inc | 4 | $79 |
| Lilly USA, LLC | 4 | $73 |
| Otsuka America Pharmaceutical, Inc. | 3 | $55 |
| Xeris Pharmaceuticals, Inc. | 1 | $39 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
| Amgen Inc. | 1 | $14 |
Products named: LEQVIO, XIFAXAN, MOUNJARO, REXULTI, Wegovy, GVOKE HYPOPEN, Ozempic, CAPLYTA.
Industry payments across TN — which companies pay providers there.
